July 7, 2020
Tenax Therapeutics Announces $8.0 Million Registered Direct and PIPE Offerings Priced At-the-Market Under Nasdaq Rules
Tenax Therapeutics in $8 million registered direct and pipe offerings priced at the market under Nasdaq rules